Aspirin metabolism may hold key to preventing preeclampsia
NCT ID NCT06802861
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how pregnant women at risk for preeclampsia process aspirin and how that relates to signs of metabolic problems. Researchers will measure aspirin byproducts in blood and urine, along with other health markers, in 50 women. The goal is to better understand why aspirin helps prevent preeclampsia in some but not others.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
aspirin
What this could lead to
If successful, this study could help doctors better understand how aspirin works to prevent preeclampsia, potentially leading to more personalized prevention plans.
What could go wrong
This is a small, early-stage observational study with only 50 participants, so results may not apply to all pregnant women. It is not testing a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Tennessee Medical Center
RECRUITINGKnoxville, Tennessee, 37920, United States
Contact Email: •••••@•••••